Safety and efficacy of oral semaglutide versus dulaglutide in Japanese patients with type 2 diabetes (PIONEER 10): an open-label, randomised, active-controlled, phase 3a trial

Publication date: May 2020Source: The Lancet Diabetes & Endocrinology, Volume 8, Issue 5Author(s): Daisuke Yabe, Jiro Nakamura, Hideaki Kaneto, Srikanth Deenadayalan, Andrea Navarria, Mette Gislum, Nobuya Inagaki, T Arisaka, T Asakura, N Azuma, S Fukuda, Y Fukushima, N Harada, S Inoue, H Ishida, H Ishii, S Ishikawa, H Jinnouchi, S Kaneko, K Kanno
Source: The Lancet Diabetes and Endocrinology - Category: Endocrinology Source Type: research